학술논문
A First-in-Human Phase 1 Dose Escalation and Expansion Study of the Oral CARD11-BCL10-MALT1 Signaling Pathway Inhibitor XL114 in Patients with Non-Hodgkin's Lymphoma
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:12055-12056
Subject
Language
ISSN
0006-4971